[The effective epidermal inhibition depth of ciclopiroxolamine and naftifin in relation to a galenic preparation].
Gehse
M
M
Küster
S
S
Gloor
M
M
D000328:Adult; D000499:Allylamine / Q000031:analogs & derivatives / Q000493:pharmacokinetics* / Q000494:pharmacology; D000588:Amines / Q000493:pharmacokinetics*; D000935:Antifungal Agents / Q000493:pharmacokinetics* / Q000494:pharmacology; D000077768:Ciclopirox; D046508:Culture Techniques; D004817:Epidermis / Q000378:metabolism* / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D011728:Pyridones / Q000493:pharmacokinetics* / Q000494:pharmacology; D012996:Solutions; D014249:Trichophyton / Q000187:drug effects*
D000588:Amines; D000935:Antifungal Agents; D011728:Pyridones; D012996:Solutions; D000077768:Ciclopirox; D000499:Allylamine; C029178:naftifine
Uber die effektive Hornschichthemmtiefe von Ciclopiroxolamin und Naftifin in Abhängigkeit von der galenischen Zubereitung.